Centuria Capital (ASX: CNI) was up around 3% in afternoon trade after the large-cap real estate funds manager posted a 63% jump in its operating profit in FY22 to $114.5m.
Centuria’s seven real estate verticals all contributed to a record period of growth during FY22.
However, management attributes reported operating earnings per share of 14.5 cents and a 10% increase in distributions from FY21 to 11 cents per share to a strong year for growth fuelled by a series of acquisitions.
To the uninitiated, the group has two key areas of focus:
Centuria Property Funds which specialises in listed property funds (A-REITs) and unlisted property funds - including the Centuria Diversified Property Fund and Centuria Healthcare Property Fund.
Centuria LifeGoals Investment Bonds which deliver innovative solutions to help clients meet their investment goals.
Joint CEOs John McBain and Jason Huljich told investors that acquisitions – which allowed the group to diversify - occurred despite the backdrop of rising inflation, covid lockdowns and geopolitical events, and provided new revenues streams in alternative asset classes such as healthcare and agriculture.
“The Group continued to scale throughout FY22 with a record number of transactions, totalling $3.1 billion,” the CEOs said.
While $2,175m of acquisitions were exchanged and settled in FY22, another $403m of acquisitions exchanged in FY22 are yet to be settled in addition to $516m of real estate finance transactions.
FY22 management fee revenue grew 77% to $146.8m over FY21
Transaction fee revenue increased 162% to $39.3m
AUM growth to $20.6bn, up 18% above FY21
$2.1bn of development pipeline opportunity
Property FUM grew to $79.4m, from $44.8m in FY21
Real estate funds management platform grew 20% to $19.8bn
Performance fees rose to $33m, from $17.9m the previous year
Centuria’s healthcare platform expanded to $1.7bn of AUM, up 55% from FY21
Commenting on today’s result, Centuria notes plans to grow its platform strongly in the alternative healthcare, agriculture and non-bank lending sectors - which are receiving strong investor demand – while remaining firmly focussed on the Australasian real estate sector.
Management also guided to operating earnings of 14.5 cents per share in FY23 and to an increased distribution of 11.6 cents per share.
“Centuria remains firmly focussed on the Australasian real estate sector,” the joint CEOs noted.
"The Group intends to grow its platform strongly in the alternative healthcare, agriculture and non-bank lending sectors which are receiving strong investor demand."
Centuria Capital’s share price is down -38% in the last 12 months.
Consensus on Centuria is Moderate Buy.
Based on Morningstar’s fair value of $2.53 the stock appears to be undervalued.
Based on the three brokers that cover Centuria (As reported on by FN Arena) the stock is currently trading with 25% upside to the target price of $2.36.
Despite an 8% bounce off its mid-June lows, Ord Minnett believes the REIT sector still appears oversold, and lifts its interest rate assumptions due to high inflation.
The broker retains a Buy rating and lowers its target price for Centuria to $2.60. (14/07/22).
Morgan Stanley expects increasing interest rates and costs of interest rate hedging to drive increased costs across its Australian property coverage.
As a result, the broker has reduced FY24-25 earnings per share forecasts by an average -8-10% across its coverage.
The broker retains an Overweight rating on Centuria with the target price decreasing to $2.50 from $3.45.
Written By
Market Index
Get the latest news and insights direct to your inbox